Clinical Trials Directory

Trials / Unknown

UnknownNCT03846271

Effects of Oxytocin on Reinforcement Learning

The Effects of Intranasal Oxytocin on Reward Sensitivity and Performance Monitoring During Reinforcement Learning: an ERP Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Electronic Science and Technology of China · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The main aim of the study is to investigate whether intranasal oxytocin (24IU) influences reward sensitivity and performance monitoring during reinforcement learning.

Detailed description

A double-blind, within-subject, placebo-controlled pharmacological EEG design will be employed. A total of 35 healthy male subjects will be recruited which will receive either intranasal placebo or oxytocin (24IU) on two separate study days (order counter-balanced, washout period at least 2 weeks). 45 minutes after treatment subjects will undergo a probabilistic feedback reinforcement learning paradigm with concurrent EEG acquisition. During the paradigm subjects will learn the reward probabilities of two different visual stimuli from probabilistic feedback provided by social stimuli (positive, negative emoticon). The paradigm includes an initial acquisition phase and a subsequent test phase.

Conditions

Interventions

TypeNameDescription
DRUGintranasal oxytocin24 IU of oxytocin nasal spray will be applied to each subject.
DRUGintranasal placeboan identical amount of placebo nasal spray will be applied to each subject.

Timeline

Start date
2018-12-04
Primary completion
2019-03-31
Completion
2019-07-31
First posted
2019-02-19
Last updated
2019-02-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03846271. Inclusion in this directory is not an endorsement.